Key result
Optimal antithrombotic regimens for bioprosthetic aortic valve replacement remain undefined due to conflicting guidelines and limited historical studies.
Why the study?
What are the optimal antithrombotic recommendations for patients following bioprosthetic aortic valve replacement?
What are the optimal antithrombotic recommendations for patients following bioprosthetic aortic valve replacement?
This review highlights the need for patient-specific anticoagulation strategies following bioprosthetic aortic valve replacement due to conflicting guidelines and limited historical data.
No takes yet. Share an insight, caveat, or question.
Undefined regimens for bioprosthetic AVR warrant individualized decisions; leaves open the need for RCTs to resolve guideline conflicts.
Efthymiou et al. (2013) studied this question. Optimal antithrombotic regimens for bioprosthetic aortic valve replacement remain undefined due to conflicting guidelines and limited historical studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: